Similarly, Jin et al. [122] found that EVs from ADSCs markedly ameliorated DN symptoms via exosomal miR-486, which led to the inhibition of the SMAD1/mTOR signaling pathway in podocytes. This evidence concerns the gene MTOR and liver dysplastic nodule.